Report ID: UCMIG35I2013 | Region: Global | Published Date: November, 2022 | Pages: 165Cyclodextrin Market
Report ID: SQSG35I2042 | Region: Global | Published Date: November, 2022 | Pages: 157
US Contraceptive market was valued at USD 8.0 billion in 2021 and it is expected to reach a value of USD 11.03 billion by 2028, at a CAGR of 4.7% over the forecast period (2022-2028).
Contraception, or birth control, is the use of medications, devices, or surgery to prevent pregnancy. Some of them are reversible, while others are irreversible. Some varieties can also aid in the prevention of sexually transmitted infections (STDs). Increased usage of contemporary contraceptives and increased knowledge of sexual health and family planning among teenagers and the young population are significant factors driving market expansion in the United States. Furthermore, government initiatives have increased access to contraceptives, which aid in the prevention of unplanned births in teens. According to the Guttmacher Institute, 60% of women of reproductive age in the United States utilize contraception. Among married women, the use of hormonal contraceptives other than the birth control pill has grown dramatically.
The increased availability of contraception in the United States has benefited various elements of society, including women's education, professional possibilities, and poverty. Access to contemporary contraceptive techniques has substantially increased job options for women and allowed them to earn pay on par with males. It has also decreased the number of women living in poverty as a result of unwanted pregnancies and the high expenditures of childrearing. The legalisation of family planning in the majority of states has lowered the economic burden for the next generation, since the number of persons living in poverty as adults have decreased significantly.
To get more reports on the above market click here to Buy The Report
US Contraceptive Market is segmented based on the product, age-group, and end-user. Based on product, the market is segmented into Pills, Intrauterine Devices (IUD) (Hormonal IUD and Nonhormonal IUD ), Condoms (Male Condoms and Female Condoms), Vaginal Ring, Subdermal Implants, Injectable, and Others. Based on age-group, the market is segmented into 15-44 years and above 44 years. Based on end-user, the market is categorized into households, clinics, and hospitals.
Analysis by Product
The contraceptive market in the United States has been divided into tablets, intrauterine devices (IUD), condoms, vaginal rings, subdermal implants, injectables, and others. Oral contraceptive pills accounted for the biggest market in 2021 due to a huge variety of products produced by numerous market participants, a high success rate (99.0% when used precisely), and the ease of use of oral pills for contraception. These medications are only accessible with a gynecologist's prescription and can be used for a variety of diseases, including dysmenorrhea, amenorrhea, hypermenorrhea, endometriosis, and others. The safety and convenience of administration of tablets have contributed to their appeal among young women in the United States.
The popularity of male condoms is high among young individuals due to easy availability, economic pricing, and added advantage of protection against STDs. Moreover, the availability of a vast range of variants in various sizes, flavors, textures, and thicknesses helps enhance sexual experience of users.
Furthermore, in the recent decade, there has been a dramatic improvement in the acceptance of long-acting reversible contraceptives. During the projected period, intrauterine devices, injectables, and vaginal rings are predicted to rise at a steady rate. The market is driven by cost-effectiveness and extended product life cycles. The introduction of new products, as well as the convenience of use of vaginal rings, are projected to boost demand for such birth control techniques.
Analysis by Age-Group
Over the course of a year, sexually active couples who do not use any form of contraception have an 85% chance of becoming pregnant. The average number of children considered ideal by adults in the United States is 2.7. A sexually active woman must use contraception for approximately three decades to achieve this family size. Contraception use among sexually active women who were not seeking pregnancy was lowest among 15-24-year-olds (83%) and highest among 25-34-year-olds (91%). More than 99% of sexually active women in the United States aged 15 to 44 have used at least one contraceptive method.
To get detailed analysis on other segments, Request For Sample Report
During the projection period, development, approval, and commercialization of novel, more effective, and long-acting reversible contraceptive techniques are likely to boost the market growth. Agile Therapeutics, for example, created Twirla, a hormonal patch that will be available in the United States in the fourth quarter of 2020. The availability of generic and low-cost medications and technologies has increased the need for contraception among teens. Furthermore, nonhormonal contraceptives are becoming increasingly popular in the United States since they reduce the danger of undesirable consequences linked with hormonal imbalance in the body. In 29 states, insurers must provide comprehensive coverage for FDA-approved contraceptive methods for women. Over-the-counter contraceptives are covered in 12 states; however, insurers may require a prescription from the beneficiary. In 20 states and the District of Columbia, insurers are required to cover a large number of contraceptives at once.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Condom use is increasing due to its dual role in birth control and the prevention of sexually transmitted diseases (STD). Furthermore, it has little to no side effects on the body.
Unmet needs among women of reproductive age in developing countries include limited access to contraception, a limited choice of methods, social and religious issues, poor quality of available services, and gender-based barriers. All of these unmet needs can increase the likelihood of unintended pregnancy. As a result, manufacturers are aiming to expand their products and services across developing economies to improve sales
Furthermore, oral contraceptives increase the risk of heart disease. IUDs are effective contraception; however, in some high-risk individuals, they increase the risk of infection. Although barrier contraception is less effective than other forms of contraception, it does protect against sexually transmitted infections such as HIV. Because of differences in the prevalence of the disorders involved, the value of non-contraceptive benefits and contraceptive risks varies by country
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Attributed to the existence of multiple enterprises, the global market is very competitive. Most businesses are pursuing strategic initiatives, such as R&D spending, in order to produce innovative goods and acquire a competitive advantage over rivals. High expenditures by well-known corporations in the commercialization of effective and long-term reversible contraception have raised public awareness of these products.
Top Player's Company Profiles
Current oral contraceptive products also include novel progestins, which have changed the scope of benefits and side effects. Approximately half of all pregnancies in the United States are unintended, and more than one in every five pregnancies in the United States ends in abortion. A study of over 10,000 women who sought abortions discovered that 46% did not use a contraceptive method during the month they conceived. Extended-cycle COCs, drospirenone-containing products, chewable contraceptive pills, and emergency contraceptive options are among the recent contraceptive advances. Sterilization is the most popular method of contraception in the United States. Many women who choose sterilization before the age of 30 later express regret and report doing so because they were unaware of equally effective reversible alternatives. In the United States, combination oral contraceptives (COCs) are the most commonly used reversible form of birth control.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our U.S. Contraceptive Market, The United States has the highest rate of adolescent pregnancy. Government activities such as promoting sex education and providing access to contraception are projected to increase the country's use of different birth control techniques. Because of their ease of use and accessibility, pills held the biggest market share in 2021. Because of the prevalence of generic medications, the country's contraceptive pill industry is very competitive. Sub dermal implants are expected to increase rapidly in the US contraceptive industry in the coming years. The subdermal implants market is largely consolidated, with only a few companies present. During the early phases of the COVID-19 epidemic, the shutdown of production operations in China and Southeast Asian nations resulted in a lack of items such as condoms and implants. Generic rivalry, industry consolidation, competing combination products, new information from clinical trials of marketed drugs, and patents issued to rivals' new goods, among other factors, have an impact on market participants' operations.
|Market size value in 2021||USD 8.0 billion|
|Market size value in 2028||USD 11.03 billion|
|Forecast Unit (Value)||USD Billion|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the US Contraceptive Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the US Contraceptive Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the US Contraceptive Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the US Contraceptive Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.SPEAK TO AN ANALYST
Get lifetime access to our reportsBasic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOW
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.
Product ID: SQSG35I2042